Calamos Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$496K Sell
1,223
-376
-24% -$152K 0.02% 236
2025
Q1
$796K Sell
1,599
-38
-2% -$18.9K 0.04% 170
2024
Q4
$852K Sell
1,637
-18,727
-92% -$9.74M 0.04% 158
2024
Q3
$12.6M Buy
20,364
+30
+0.1% +$18.6K 0.65% 38
2024
Q2
$11.2M Buy
20,334
+334
+2% +$185K 0.6% 40
2024
Q1
$11.6M Buy
20,000
+18,309
+1,083% +$10.6M 0.65% 38
2023
Q4
$898K Sell
1,691
-16,723
-91% -$8.88M 0.06% 142
2023
Q3
$9.32M Buy
18,414
+69
+0.4% +$34.9K 0.71% 37
2023
Q2
$9.57M Sell
18,345
-575
-3% -$300K 0.7% 29
2023
Q1
$10.9M Buy
18,920
+16,015
+551% +$9.23M 0.85% 24
2022
Q4
$1.6M Sell
2,905
-88
-3% -$48.5K 0.12% 111
2022
Q3
$1.52M Sell
2,993
-62
-2% -$31.4K 0.13% 108
2022
Q2
$1.66M Buy
3,055
+40
+1% +$21.7K 0.15% 108
2022
Q1
$1.78M Buy
3,015
+146
+5% +$86.2K 0.13% 116
2021
Q4
$1.91M Sell
2,869
-98
-3% -$65.4K 0.14% 112
2021
Q3
$1.7M Sell
2,967
-63
-2% -$36K 0.14% 112
2021
Q2
$1.53M Sell
3,030
-10,514
-78% -$5.31M 0.12% 125
2021
Q1
$6.18M Sell
13,544
-5,116
-27% -$2.33M 0.51% 54
2020
Q4
$8.69M Buy
18,660
+1,109
+6% +$517K 0.79% 29
2020
Q3
$7.75M Buy
17,551
+1,213
+7% +$536K 0.89% 21
2020
Q2
$5.92M Buy
16,338
+1,602
+11% +$580K 0.74% 32
2020
Q1
$4.18M Buy
14,736
+13,976
+1,839% +$3.96M 0.64% 46
2019
Q4
$247K Hold
760
0.03% 214
2019
Q3
$221K Hold
760
0.03% 217
2019
Q2
$223K Hold
760
0.03% 217
2019
Q1
$208K Buy
+760
New +$208K 0.03% 210
2018
Q1
Sell
-14,337
Closed -$2.72M 231
2017
Q4
$2.72M Sell
14,337
-1,675
-10% -$318K 0.35% 73
2017
Q3
$3.03M Buy
16,012
+136
+0.9% +$25.7K 0.42% 72
2017
Q2
$2.77M Buy
15,876
+184
+1% +$32.1K 0.39% 74
2017
Q1
$2.41M Buy
15,692
+3,400
+28% +$522K 0.36% 84
2016
Q4
$1.73M Sell
12,292
-11,056
-47% -$1.56M 0.28% 109
2016
Q3
$3.71M Buy
23,348
+2,047
+10% +$326K 0.63% 49
2016
Q2
$3.15M Buy
21,301
+12,765
+150% +$1.89M 0.56% 52
2016
Q1
$1.21M Buy
8,536
+1,546
+22% +$219K 0.23% 132
2015
Q4
$992K Buy
+6,990
New +$992K 0.2% 148